课题基金 / 基金详情

Forced expression of the TNF-family gene in lung cancer cells produced therapeutic effects, stimulating antigen-presentation processes.

Forced expression of the TNF-family gene in lung cancer cells produced therapeutic effects, stimulating antigen-presentation processes.
肺癌细胞中 TNF 家族基因的强制表达产生了治疗效果,刺激了抗原呈递过程。
批准号:
12671337
负责人:
KOSHIKAWA Nobuko
金额:
$2.18万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

KOSHIKAWA Nobuko的其他基金

相似基金

相关文献

中文摘要
翻译
负责细胞介导免疫的细胞毒性T细胞的诱导需要在抗原呈递中起关键作用的树突状细胞(DC)的活化。在这项研究中,我们研究了是否可以通过转移TNF家族基因来激活DC,从而对肺癌细胞产生抗肿瘤作用。小鼠肺癌刘易斯细胞转染TNF家族基因,并建立克隆皮下接种到同基因小鼠。表达CD 40配体的肿瘤的生长与母瘤相比显著减慢,自发性肺转移灶的数量显著减少。接种Fas配体表达的肿瘤的免疫活性小鼠没有发生肿瘤,并且小鼠产生了肿瘤特异性保护性免疫。小鼠未产生任何肺转移灶。TNF-α表达的肿瘤的生长与母瘤的生长无差异,但转移灶的数量显著减少。为了分析DC在这种抗肿瘤作用中的参与,我们将从骨髓细胞中获得的DC与转染细胞共培养。DC与表达Fas配体的肿瘤形成簇,但与母瘤不形成簇。在与表达CD 40配体的肿瘤共培养期间,DC的活化标记物、共刺激分子CD 86的表达上调。Fas配体和CD 40配体可能分别参与DC的抗原加工和成熟。
英文摘要
Induction of cytotoxic T cells, responsible for cell-mediated immunity, requires the activation of dendritic cells (DC) which play a crucial role in antigen-presentation. We examined in this study whether activation of DC could be performed by gene transfer of the TNF-family gene and consequently antitumor effects were produced against lung cancer cells. Murine lung carcinoma Lewis cells were transfected with the TNF-family gene and established clones were subcutaneously inoculated into syngeneic mice. The growth of CD40 ligand-expressed tumors was significantly retarded compared with that of parent tumors and the number of spontaneous lung metastatic foci was significantly reduced. The immunocompetent mice that were inoculated with the Fas ligand-expressed tumors did not developed tumors and the mice generated tumor-specific protective immunity. The mice did not produce any lung metastatic foci. The growth of the TNF-α-expressed tumors was not different from that of parent tumors but the number of metastatic foci was significantly decreased. In order to analyze the involvement of DC in this antitumor effects, we cocultured DC that were obtained from bone-marrow cells with the transfected cells. DC formed cluster with Fas ligand-expressed but not parent tumors. The expression of CD86, an activation marker an costimulatory molecule of DC, was upregulated during the coculture with CD40 ligand-expressed tumors. Fas ligand and CD40 ligand seem to be involved in antigen processing and maturation of DC, respectively.
期刊论文(34)
专著(0)
科研奖励(0)
会议论文
Tada, Y., O-Wang, J., Takiguchi, Y., Tatsumi, K., Kuriyama, T. and Tagawa, M.: "T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells"Int. J. Mol. Med. (in press).
Tada, Y.、O-Wang, J.、Takiguchi, Y.、Tatsumi, K.、Kuriyama, T. 和 Takawa, M.:“小鼠肺上 Fas 配体表达产生的 T 细胞依赖性和非依赖性抗肿瘤免疫
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Narita M, Tagawa M, et al.: "Tissite-specific expression of a suicide gene for selective killing of rieuroblastoma cells using a promoter region of the NCX gene"Cancer Gene Ther.. 8. 997-1002 (2001)
Narita M,Takawa M,等人:“使用NCX基因的启动子区域选择性杀死神经母细胞瘤细胞的自杀基因的Tissite-specific表达”Cancer Gene Ther.. 8. 997-1002 (2001)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
25
    Comparison of the frequency of mtDNA mutation in primary and metastatic lesions of human malignant tumors
    • 批准号:
      21590349
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2009
    • 负责人:
      KOSHIKAWA Nobuko
    • 依托单位:
    Effect of HIF inhibitors on tumor hypoxia-induced dedifferentiation and metastasis of lung carcinoma cells
    • 批准号:
      19591655
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.41万
    • 财政年份:
      2007
    • 负责人:
      KOSHIKAWA Nobuko
    • 依托单位:
    Cell-cidal effect of the combination therapy of p53 gene under the control of radiation- and hypoxia-sensitized promoter and heavy particle irradiation in glioma
    • 批准号:
      16591466
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      2004
    • 负责人:
      KOSHIKAWA Nobuko
    • 依托单位:
    国内基金
    海外基金
    CD40 ligand 转基因B淋巴瘤细胞来源exosome的抗肿瘤作用
    • 批准号:
      81071948
    • 项目类别:
      面上项目
    • 资助金额:
      10.0万元
    • 批准年份:
      2010
    • 负责人:
      刘爱春
    • 依托单位: